AbCellera Biologics (ABCL) Stock Price & Financial Analysis
AbCellera Biologics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About AbCellera Biologics
What is the current stock price for ABCL?
As of the latest trading session, ABCL stock trades at $5.62. The 52-week range is $2.38–$6.79, with a day range of $5.50–$6.33.
What is the P/E ratio for ABCL?
The P/E ratio (Price-to-Earnings) for ABCL is shown in the Key Statistics section. This valuation metric helps compare AbCellera Biologics Inc. to industry peers.
Does ABCL pay dividends?
AbCellera Biologics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ABCL?
Based on 1 analyst, the consensus for ABCL is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of ABCL?
AbCellera Biologics's market capitalization is $1.68B, classifying it as a small-cap company..